Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma

Webinar | March 13, 2024, 12 PM EST.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

Svag krona ingen nackdel för läkemedelsföretag

Läkemedels- och kemiföretag hör till vinnarna när den svenska kronan är svag, enligt en ny undersökning som bygger på intervjuer med representanter för företag.

CTC Clinical Trial Consultants AB

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

TECHNIA AB

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Cytel Sweden

Zelmic

A+ Science AB

Meribel Pharma Solna

Metabolon

RegFile AB

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

LINK Medical Research

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

Kompauto Nordic AB

Merck Life Science A/S

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Bio-Works

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.